Cargando…
A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases
[Image: see text] A novel fragment-based drug discovery approach is reported which irreversibly tethers drug-like fragments to catalytic cysteines. We attached an electrophile to 100 fragments without significant alterations in the reactivity of the electrophile. A mass spectrometry assay discovered...
Autores principales: | Kathman, Stefan G., Xu, Ziyang, Statsyuk, Alexander V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113264/ https://www.ncbi.nlm.nih.gov/pubmed/24870364 http://dx.doi.org/10.1021/jm500345q |
Ejemplares similares
-
Naphthoquinones as Covalent Reversible Inhibitors of Cysteine Proteases—Studies on Inhibition Mechanism and Kinetics
por: Klein, Philipp, et al.
Publicado: (2020) -
Synthesis of the Novel Covalent Cysteine Proteases Inhibitor with Iodoacetic Functional Group
por: Hartman, Kinga, et al.
Publicado: (2020) -
Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer
por: Thiyagarajan, Thirumagal, et al.
Publicado: (2022) -
Development of a Selection Method for Discovering Irreversible
(Covalent) Binders from a DNA-Encoded Library
por: Zhu, Zhengrong, et al.
Publicado: (2018) -
Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors
por: Keeley, A., et al.
Publicado: (2018)